Pharmaceutical Follow-up Program for Patients with Oral Drug Treatment in Non-small Cell Lung Cancer in a Heterogeneous Health Care System

被引：1

作者：

Moreira, G. ^{[1
]}

Ferreira, C. G. ^{[1
]}

Montella, T. ^{[1
]}

Vasconcellos, J. ^{[1
]}

Goncalves, I. ^{[1
]}

机构：

[1] Grp Oncoclin, Rio De Janeiro, Brazil

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期

关键词：

Oral drug; target therapy; clinical pharmacist;

D O I：

10.1016/j.jtho.2019.09.161

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.26

引用

页码：S1184 / S1184

页数：1

共 50 条

[31] Health Care Professionals' Views of the Follow-up of Lung Cancer Patients
Calman, L.
Beaver, K.
Roberts, C.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S322 - S323
[32] Long-term survival following pneumonectomy for non-small cell lung cancer - Clinical implications for follow-up care
Kim, Dae Joon
Lee, Jin Gu
Lee, Chang Young
Park, In-kyu
Chung, Kyung Young
CHEST, 2007, 132 (01) : 178 - 184
[33] Patterns of Follow-Up Care After Curative Radiotherapy for Stage I-III Non-Small Cell Lung Cancer
Mohan, S.
Shafiq, J.
Beydoun, N.
Nasser, E.
Nguyen, A.
Vinod, S.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2331 - S2331
[34] Follow-Up on Results of a Multidisciplinary Team in the Management of Non-Small Cell Lung Cancer in a Developing Country
Corrales-Rodriguez, Luis
Juarez, Melissa
Ramos-Esquivel, Allan
Caballero, Manuel
Araya, Monica
Rodriguez, Warner
Volio, Andres
Zuniga, Carlos
Valladares, Rene
Villalobos, Manuel
Solis, Bruno
Guadamuz, Randall
Antillon, Sofia
Campos, Christian
Soto, Tatiana
Murillo, Adriana
Brenes, Alejandro
Rivera, Tania
Rodriguez, Luis
Baptista, Joao
Zeledon, Zenen
Ordonez, Pablo
Jimenez, Ernesto
Gonzalez, Ileana
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S185 - S186
[35] Recurrence Dynamic of Completely Resected Non-Small Cell Lung Cancer in Perspective of Follow-Up Surveillance
Kim, Eung Rae
Park, In Kyu
Hyun, Kwanyong
Park, Samina
Hwang, Yoohwa
Kang, Chang Hyun
Kim, Young Tae
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1395 - S1395
[36] Continued smoking after successful treatment in patients with resectable non-small cell lung cancer: A 12-month follow-up study
Mikami, I
Akizuki, N
Akechi, T
Yamawaki, S
Uchitomi, S
PSYCHO-ONCOLOGY, 2004, 13 (08) : S88 - S89
[37] Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States
Hess, Lisa M.
Cui, Zhanglin Lin
Li, Xiaohong Ivy
Oton, Ana B.
Shortenhaus, Scott
Watson, Ian A.
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 755 - 761
[38] Follow-up and Recurrence After Surgery in Patients with Non-Small-Cell Lung Cancer
Martelo, F.
Felizardo, M.
Fernandes, M. O.
Pantarroto, M.
Grafino, M.
Reis, J. Eurico
Catarino, A.
Ribeiro, A.
Loewenthal, C.
Vieira, R.
Mascarenhas, F.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1013 - S1014
[39] The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer
Edwards, Camille, V
Sheikh, Ayesha R.
Dennis, Michael J.
Hunter, Andrew
Mackay, Zoe P.
Catudal, Evan C.
Elias, Rawad
Cabral, Howard J.
Sarosiek, Shayna R.
Tapan, Umit
JOURNAL OF THORACIC DISEASE, 2022, : 3865 - 3875
[40] Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302).
Westeel, Virginie
Barlesi, Fabrice
Domas, Jean
Girard, Philippe
Foucher, Pascal
Lafitte, Jean-Jacques
Dumont, Patrick
Wislez, Marie
Quoix, Elisabeth A.
Braun, Denis
Lebitasy, Marie Paule
Hermann, Jacques
Derollez, Marc
Ozenne, Gervais
Raffy, Olivier
Devin, Etienne
Barbieux, Hubert
Tredaniel, Jean
Morin, Franck
Debieuvre, Didier
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

← 1 2 3 4 5 →